CollPlant Biotechnologies (CLGN) Scheduled to Post Earnings on Wednesday

CollPlant Biotechnologies (NASDAQ:CLGN) is set to announce its earnings results before the market opens on Wednesday, November 27th. Analysts expect the company to announce earnings of ($0.37) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

CollPlant Biotechnologies Stock Performance

Shares of CollPlant Biotechnologies stock opened at $4.14 on Monday. The business’s 50 day simple moving average is $4.34 and its 200 day simple moving average is $4.88. CollPlant Biotechnologies has a 52-week low of $3.31 and a 52-week high of $6.99. The firm has a market cap of $47.40 million, a PE ratio of -2.69 and a beta of 0.44.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. EF Hutton Acquisition Co. I raised CollPlant Biotechnologies to a “strong-buy” rating in a research report on Monday, August 5th. HC Wainwright reiterated a “buy” rating and issued a $11.00 price objective on shares of CollPlant Biotechnologies in a research note on Wednesday, August 21st.

CollPlant Biotechnologies Company Profile

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology.